Purchases and Sales Made in Q4 2024 in Zentalis Pharmaceuticals, Inc. (ZNTL)
This table provides information about the institutional ownership of Zentalis Pharmaceuticals, Inc. (ZNTL) during Q4 2024. The information is specifically focused on institutions that hold shares of Zentalis Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Jan 17, 2025
Q4 2024
|
Sg Americas Securities, LLC
|
BUY
|
- |
30.2K+ 115.64% |
$81.6K - $122K
|
56.4K
$98.1K
|
|
|
Jan 28, 2025
Q4 2024
|
Savant Capital, LLC
|
BUY
|
- |
23.9KNew |
$64.5K - $96.3K
|
23.9K
$41.6K
|
|
|
Jan 31, 2025
Q4 2024
|
Ieq Capital, LLC
|
BUY
|
- |
15.1KNew |
$40.8K - $60.9K
|
15.1K
$26.3K
|
|
|
Jan 15, 2025
Q4 2024
|
Skopos Labs, Inc.
Riverhead, NY |
BUY
|
- |
7.4KNew |
$20K - $29.8K
|
7.4K
$12.9K
|
|
|
Jan 30, 2025
Q4 2024
|
Rhumbline Advisers
Boston, MA |
BUY
|
- |
5.5K+ 6.34% |
$14.9K - $22.2K
|
92.2K
$160K
|
|
|
Jan 22, 2025
Q4 2024
|
Ronald Blue Trust, Inc.
Brentwood, TN |
BUY
|
- |
1.07K+ 276.55% |
$2.9K - $4.32K
|
1.46K
$2.54K
|
|
|
Jan 17, 2025
Q4 2024
|
Nisa Investment Advisors, LLC
|
BUY
|
- |
749+ 619.01% |
$2.02K - $3.02K
|
870
$1.51K
|
|
|
Jan 29, 2025
Q4 2024
|
Values First Advisors, Inc.
|
SELL
|
- |
-38.5K- 51.65% |
$104K - $155K
|
36K
$62.7K
|